Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
p38 mitogen-activated protein kinases (MAPKs) are a class of serine/threonine protein kinases that play a central role in cellular responses to stress and inflammation. They are activated by various extracellular stimuli, including cytokines, ultraviolet irradiation, heat shock, osmotic shock, oxidative stress, and growth factors. The p38 MAPK pathway is evolutionarily conserved and is involved in regulating cell differentiation, apoptosis, autophagy, and inflammatory responses. There are four main isoforms: p38α (MAPK14), p38β (MAPK11), p38γ (MAPK12/ERK6), and p38δ (MAPK13/SAPK4). Activation typically follows a three-tiered kinase cascade: MAPKKKs activate MKKs, which phosphorylate p38 isoforms on a TGY motif. Activated p38 MAPKs phosphorylate numerous substrates, regulating inflammation, cell cycle arrest, and apoptosis. Given their role in inflammation, components of the p38 pathway are considered potential therapeutic targets for autoimmune diseases, chronic inflammatory conditions, neurodegenerative disorders, and cancer.
ATP-competitive inhibition (for small molecule inhibitors); Dephosphorylation by phosphatases (endogenous regulation)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on p38 Mitogen-Activated Protein Kinase (p38 MAPK).